Drugs / IAG933
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04857372 | Oct 2021 → Jan 2027 expected | mesothelioma | Novartis Pharmaceuticals | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IAG933 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04857372 ↗ |
| Route | Oral | “Oral IAG933” NCT04857372 ↗ |